Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia.
D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced*; D005164:Factor IX / Q000009:adverse effects* / Q000627:therapeutic use; D015949:Factor IXa; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications; D008297:Male; D008875:Middle Aged
D005164:Factor IX; D015949:Factor IXa